通訊作者

• Li-Hsin Chang, Ting-Ting Chang, Chia-Huei Chu, Chin-Chou Huang, Liang-Yu Lin. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus. Clinica Chimica Acta. [IF 5.0]

第一加通訊作者

• Lin LY, Chang TT, Leu HB, Huang CC, Wu TC, Chou RH, Huang PH, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, Chang KC, Wang JH, Wu CC, *Chen JW. Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clin Res Cardio. 2024 April 30. [IF 5.0]

共同作者

• Chang TT, Lin LY, Chen C, Chen JW. CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation. Angiogenesis. 2024 April 15. [IF:9.8]
• Chen C, Lin LY, Wu YW, Chen JW, Chang TT. CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease. Clin Immunol. 2024 Sep 24. [IF 4.5]
•  Chang TT, Li YZ, Mo HW, Chen C, Lin LY, Chang CC, Chen JW. CCL7 is a novel target for endothelial dysfunction and vasculopathy in diabetes mellitus. Science Translational Medicine. 2024 Nov 4. [IF 15.8]